APP and Alzheimer disease: Among these, the dysregulated production of Aβ through sequential cleavage of amyloid precursor protein (APP) by β-site APP-cleaving enzyme 1 (BACE1) and γ-secretase has been recognized as a critical initiating event in AD pathogenesis [6,7].